AXS Stock Analysis: AXIS Capital Holdings | NYSE
Insurance - Specialty | NYSE, USA | Market Cap: 8.015m USD | 12M Return: 16.9% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 70.3M
EPS Trend: 90.2%
Qual. Beats: 0
Rev. Trend: 99.3%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
AXIS Capital Holdings Limited (NYSE: AXS) is a Bermuda-based specialty insurer and reinsurer operating through two segments: Insurance and Reinsurance. Founded in 2001 and headquartered in Pembroke, Bermuda, the company serves clients in Bermuda, the United States, and other international markets.
The Insurance segment provides specialty lines including professional liability (directors and officers liability, errors and omissions, medical malpractice, cyber), commercial and residential property, marine and aviation, personal accident and travel, and credit and political risk coverages. The Reinsurance segment writes agriculture, catastrophe, accident and health, credit and surety, motor, life, engineering, property, and liability reinsurance, among other lines.
AXS is classified under the GICS Property & Casualty Insurance sub-industry within the Financials sector and trades as a mid-cap stock. Bermuda is one of the worlds largest domiciles for specialty insurance and reinsurance companies, with a regulatory and capital framework designed to support complex, internationally distributed risk portfolios.
- Reinsurance rates harden on elevated catastrophe losses
- Specialty insurance premium growth driven by cyber and professional lines
- Higher investment income boosts underwriting margins across segments
| Net Income: 1.07b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -4.84 > 1.0 |
| NWC/Revenue: 203.3% < 20% (prev 226.7%; Δ -23.43% < -1%) |
| CFO/TA 0.00 > 3% & CFO 169.4m > Net Income 1.07b |
| Net Debt (-4.20b) to EBITDA (1.44b): -2.92 < 3 |
| Current Ratio: 2.53 > 1.5 & < 3 |
| Outstanding Shares: last quarter (75.2m) vs 12m ago -8.77% < -2% |
| Gross Margin: 40.54% > 18% (prev 28.90%; Δ 11.64% > 0.5%) |
| Asset Turnover: 19.20% > 50% (prev 18.18%; Δ 1.03% > 0%) |
| Interest Coverage Ratio: 20.21 > 6 (EBIT TTM 1.34b / Interest Expense TTM 66.5m) |
| A: 0.38 (Total Current Assets 22.3b - Total Current Liabilities 8.81b) / Total Assets 35.6b |
| B: 0.24 (Retained Earnings 8.40b / Total Assets 35.6b) |
| C: 0.04 (EBIT TTM 1.34b / Avg Total Assets 34.4b) |
| D: 0.22 (Book Value of Equity 6.38b / Total Liabilities 29.2b) |
| Altman-Z'' = 3.74 = AA |
| DSRI: 1.09 (Receivables 13.5b/11.3b, Revenue 6.61b/6.04b) |
| GMI: 0.71 (GM 28.90% / 40.54%) |
| AQI: 1.08 (AQ_t 0.37 / AQ_t-1 0.35) |
| SGI: 1.09 (Revenue 6.61b / 6.04b) |
| TATA: 0.03 (NI 1.07b - CFO 169.4m) / TA 35.6b) |
| Beneish M = -3.10 (Cap -4..+1) = AA |
As of July 07, 2026, the stock is trading at USD 113.36 with a total of 754,200 shares traded. Over the past week, the price has changed by +8.72%, over one month by +15.19%, over three months by +12.18% and over the past year by +16.94%.
Current recommended Stop Loss: 109.60 (which is 3.3% or 1.5 ATR below the current price).
AXIS Capital Holdings has received a consensus analysts rating of 4.11. Therefore, it is recommended to buy AXS.
- StrongBuy: 4
- Buy: 2
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 122 | 7.6% |
P/E Trailing = 8.1256
P/E Forward = 8.1367
P/S = 1.1989
P/B = 1.3747
P/EG = 1.1787
Revenue TTM = 6.61b USD
EBIT TTM = 1.34b USD
EBITDA TTM = 1.44b USD
Long Term Debt = 1.38b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 1.60b USD (from shortLongTermDebtTotal, last quarter) + Leases 110.2m
Net Debt = -4.20b USD (calculated: Debt 1.60b - CCE 5.80b)
Enterprise Value = 3.82b USD (8.02b + Debt 1.60b - CCE 5.80b)
Interest Coverage Ratio = 20.21 (Ebit TTM 1.34b / Interest Expense TTM 66.5m)
EV/FCF = 22.53x (Enterprise Value 3.82b / FCF TTM 169.4m)
FCF Yield = 4.44% (FCF TTM 169.4m / Enterprise Value 3.82b)
FCF Margin = 2.56% (FCF TTM 169.4m / Revenue TTM 6.61b)
Net Margin = 16.18% (Net Income TTM 1.07b / Revenue TTM 6.61b)
Gross Margin = 40.54% ((Revenue TTM 6.61b - Cost of Revenue TTM 3.93b) / Revenue TTM)
Gross Margin QoQ = 47.23% (prev 50.45%)
Tobins Q-Ratio = 0.11 (Enterprise Value 3.82b / Total Assets 35.6b)
Interest Expense / Debt = 4.15% (Interest Expense 66.5m / Debt 1.60b)
Taxrate = 17.62% (228.2m / 1.30b)
NOPAT = 1.11b (EBIT 1.34b * (1 - 17.62%))
Current Ratio = 2.53 (Total Current Assets 22.3b / Total Current Liabilities 8.81b)
Debt / Equity = 0.25 (Debt 1.60b / totalStockholderEquity, last quarter 6.38b)
Debt / EBITDA = -2.92 (Net Debt -4.20b / EBITDA 1.44b)
Debt / FCF = -24.78 (Net Debt -4.20b / FCF TTM 169.4m)
Total Stockholder Equity = 6.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.11% (Net Income 1.07b / Total Assets 35.6b)
RoE = 16.93% (Net Income TTM 1.07b / Total Stockholder Equity 6.32b)
RoCE = 17.45% (EBIT 1.34b / Capital Employed (Equity 6.32b + L.T.Debt 1.38b))
RoIC = 4.18% (NOPAT 1.11b / Invested Capital 26.5b)
WACC = 6.07% (E(8.02b)/V(9.62b) * Re(6.60%) + D(1.60b)/V(9.62b) * Rd(4.15%) * (1-Tc(0.18)))
Discount Rate = 6.60% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -85.40 | Cagr: -5.46%
[DCF] Terminal Value 73.10% ; FCFF base≈809.2m ; Y1≈709.7m ; Y5≈573.4m
[DCF] Fair Price = 181.8 (EV 9.20b - Net Debt -4.20b = Equity 13.4b / Shares 73.7m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 90.15 | EPS CAGR: 21.68% | SUE: -0.71 | # QB: 0
Revenue Correlation: 99.25 | Revenue CAGR: 6.99% | SUE: -0.61 | # QB: 0
EPS current Quarter (2026-06-30): EPS=3.44 | Chg30d=+0.00% | Revisions=-21% | Analysts=12
EPS next Quarter (2026-09-30): EPS=2.98 | Chg30d=+0.00% | Revisions=-31% | Analysts=12
EPS current Year (2026-12-31): EPS=13.23 | Chg30d=-0.08% | Revisions=-36% | GrowthEPS=+2.4% | GrowthRev=+6.6%
EPS next Year (2027-12-31): EPS=14.51 | Chg30d=+0.00% | Revisions=-25% | GrowthEPS=+9.7% | GrowthRev=+6.1%
[Analyst] Revisions Ratio: -34% (up=13, down=28)